Celadon Pharmaceuticals Plc (CEL.L) LSE

13.40

+1.9(+16.52%)

Updated at July 01, 2025 07:30AM

Currency In GBp

Valuation

Market Cap71.18M
Enterprise Value74.64M
P/E Ratio-1.16
PEG Ratio-0.01
Price/Sales Ratio123
Price/Book Ratio2.63
Enterprise/Revenue169.11
Enterprise/EBITDA-1.98

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-95.2
Operating Margin-79.08

Management Effectiveness

Return On Assets-0.77
Return On Equity-1.32

Income Statement

Revenue75,000
Revenue/Share0
Gross Profit1,000
EBITDA-6.39M
Net Income-7.14M
Diluted EPS-0.12

Balance Sheet

Total Cash16,000
Total Cash/Share0.02
Total Debt4.78M
Total Debt/Equity1.49
Current Ratio2.62
Book Value Per Share0.05

Price History

52-Week Change-78.56
52-Week High83
52-Week Low0.06
Moving Average 50 Days7.86
Moving Average 200 Days16.42

Statistics

Average Volume182,287
Shares Outstanding68.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A